Sir David Weatherall reflects on genetics and personalized medicine. Interviewed by Ulrike Knies-Bamforth.

Drug discovery today

Volumn 11, Issue 13-14, 2006, Pages 576-579

  Weatherall, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; DEVELOPING COUNTRY; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG THERAPY; GENETICS; HEALTH SERVICE; HUMAN; INTERVIEW; PHARMACOGENETICS; THALASSEMIA; UNITED KINGDOM; UNITED STATES; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC AGENTS; DEVELOPING COUNTRIES; DRUG DELIVERY SYSTEMS; DRUG INDUSTRY; DRUG THERAPY; GREAT BRITAIN; HUMANS; PERSONAL HEALTH SERVICES; PHARMACOGENETICS; THALASSEMIA; UNITED STATES; WORLD HEALTH ORGANIZATION;

MLCS; MLOWN;

EID: 39049195108     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2006.05.007     Document Type: Article

References (0)